Zydus Lifesciences Ltd Quarterly Results
Q3 FY25-26 Results Summary
Revenue
The revenue stands at ₹6,864.50 crore, reflecting a quarter-on-quarter *(QoQ) increase of 12.11 per cent from ₹6,123.20 crore. This corresponds to a year-on-year *(YoY) growth of 30.28 per cent.
Operating Profit
Operating Profit stands at ₹241.30 crore, reflecting a quarter-on-quarter *(QoQ) increase of 14.74 per cent from ₹210.30 crore. This corresponds to a year-on-year *(YoY) growth of 169.61 per cent.
PBDT
PBDT stands at ₹747.90 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 1.06 per cent from ₹755.90 crore. This corresponds to a year-on-year *(YoY) growth of 83.08 per cent.
Profit Before Tax
Profit Before Tax stands at ₹1,411.20 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 16.63 per cent from ₹1,692.60 crore. This corresponds to a year-on-year *(YoY) growth of 17.04 per cent.
Net Profit
Net Profit stands at ₹1,127.00 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 12.82 per cent from ₹1,292.80 crore. This represents a 10.08 per cent year-on-year *(YoY) growth for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Zydus Lifesciences Ltd News
Zydus Lifesciences Ltd Earnings
- YOY
- QOQ
Zydus Lifesciences Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Zydus Lifesciences Ltd Research Reports
Zydus Lifesciences Ltd Financial Reports
Zydus Lifesciences Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Zydus Lifesci. | -3.64% | -2.00% | -0.89% | -6.75% | -7.23% | -5.05% |
| Cipla | -0.03% | 0.71% | -8.45% | -11.70% | -11.74% | -7.43% |
| Dr Reddy's Labs | -1.19% | 0.96% | 3.41% | 2.27% | 2.99% | 3.39% |
| Lupin | -0.37% | -0.68% | 0.58% | 8.18% | 13.30% | 8.76% |
| Mankind Pharma | -0.56% | -0.37% | -6.83% | -8.73% | -14.65% | -14.31% |
| Alkem Lab | 1.19% | 2.46% | -1.14% | 0.63% | 12.64% | 23.21% |
| Aurobindo Pharma | -6.57% | -5.09% | -4.29% | -5.54% | 6.08% | -2.00% |
Company Info
Company Information
Chairman (Non-Executive) : Pankaj R Patel
Managing Director : Sharvil P Patel
Non Executive Director : Mukesh M Patel
Independent Director : Apurva S Diwanji
Whole-time Director : Ganesh N Nayak
Independent Director : Bhadresh K Shah
Company Sec. & Compli. Officer : Dhaval N Soni
Independent Director : Akhil A. Monappa
Independent Director : Upasana Konidela.
Independent Director : Shelina P. Parikh